Thank you very much for your presentation, Mr. Glover, Ms. Mullin, and Ms. Sabourin.
In countries that have dealt successfully with this drug shortage, such as New Zealand and the United States, they do a couple of important things: they identify the drugs that are going to be short, they anticipate, and they manage.
Now given that you, as a federal government, are responsible for regulation and approval, you have a huge role to play in identifying and managing and fast-forwarding areas where you think there's going to be a shortage and in other areas involving manufacturing the drugs, etc. There is a role.
We heard from many people who presented here that the Food and Drug Administration has been very successful in using their mandate to predict, identify, and manage shortages. First and foremost, patients need medication when they need medication. Many patients who don't get that medication could die or could be severely impaired for the rest of their lives.
When we start talking about whose jurisdiction is what, it becomes moot. It isn't really about who you pick up the phone and call; it is about whether the patient gets the drug and gets to be well. At the end of the day, I think the responsibility rests with the people who regulate the drugs and who are able to work with others—as I would like to say, a leader—to try to find a way around this problem. It's about human beings. It's about Canadians. It's about protecting them and caring for them.
We're trying to find a resolution here. It's not a case of fault or blame. Could we put that aside for a minute?
In November 2011 the Food and Drug Administration told Sandoz that they did not comply with manufacturing standards. Was your department aware of that in November 2011? Were you aware then of what that impact could be on real people? I hope you didn't know. If you had, I would have thought you would have felt it was a moral obligation to warn people that this was going to happen, so that doctors, anesthetists, pharmacists, hospitals, etc. could start stockpiling.
Were you aware of the November 2011 FDA ruling? If you were, did you tell people? Did you warn them? If you didn't, why not? That's my first question.
Second, I continue to hear the federal government saying that they are just regulators and approvers, but you're the fifth-largest deliverer of health care in this country, so you're not just regulators and approval parties. You actually deliver services to the armed forces, the Inuit, the first nations, etc., so you need to know how these people you deliver services to are going to be able to get their medications and be able to get help.
Can you give me an answer about your knowledge of Sandoz and about thinking a federal leadership role is required, first in delivering care to the people you need to and second in terms of coming together and working with the provinces to make sure Canadians get drugs?